Suchergebnisse - "Takashima, Atsuo"

PubPharm (342)

21

Utility of circulating tumour DNA for prognosis and prediction of therapeutic effect in locally recurrent rectal cancer : study protocol for a multi-institutional, prospective observational study (JCOG1801A1, CAP-LR study)

enthalten in: BMJ open | 2023

von Hashimoto, T. | Tsukada, Y. | Ito, M. | +6

22

Prognostic factors associated with the transition in treatment methods for brain metastases from colorectal cancer

enthalten in: International journal of clinical oncology | 2023

von Imaizumi, J. | Shida, D. | Boku, N. | +6

23

Definitive S-1/mitomycin-C chemoradiotherapy for stage II/III anal canal squamous cell carcinoma : a phase I/II dose-finding and single-arm confirmatory study (JCOG0903)

enthalten in: International journal of clinical oncology | 2023

von Ito, Y. | Hamaguchi, T. | Takashima, A. | +21

24

Phase II biomarker identification study of anti-VEGF agents with FOLFIRI for pretreated metastatic colorectal cancer

enthalten in: Future oncology (London, England) | 2023

von Hashimoto, T. | Otsu, S. | Hironaka, S. | +7

25

Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer : APOLLO-11 study

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2023

von Takahari, D. | Katai, H. | Takashima, A. | +18

26

Definitive S-1/mitomycin-C chemoradiotherapy for stage II/III anal canal squamous cell carcinoma: a phase I/II dose-finding and single-arm confirmatory study (JCOG0903)

enthalten in: International journal of clinical oncology | 2023

von Ito, Y. | Hamaguchi, T. | Takashima, A. | +20

27

Definitive S-1/mitomycin-C chemoradiotherapy for stage II/III anal canal squamous cell carcinoma: a phase I/II dose-finding and single-arm confirmatory study (JCOG0903)

enthalten in: International journal of clinical oncology | 2023

von Ito, Y. | Hamaguchi, T. | Takashima, A. | +20

28

Prognostic factors associated with the transition in treatment methods for brain metastases from colorectal cancer

enthalten in: International journal of clinical oncology | 2023

von Imaizumi, J. | Shida, D. | Boku, N. | +6

29

Prognostic factors associated with the transition in treatment methods for brain metastases from colorectal cancer

enthalten in: International journal of clinical oncology | 2023

von Imaizumi, J. | Shida, D. | Boku, N. | +6

30

Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer : a randomised noninferiority trial

enthalten in: British journal of cancer | 2023

von Kuboki, Y. | Terazawa, T. | Masuishi, T. | +21